Canaccord Genuity Reiterates a 'Buy' on RTI Biologics (RTIX); Beat and Raise in Difficult Market; Spine Outperformed
Tweet
Share
E-mailGet Alerts RTIX Hot Sheet
Price: $3.14 --0%
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on RTI Biologics (NASDAQ: RTIX), raises PT from $5.25 to $6.00.
Canaccord analyst, William J. Plovanic, says, "We reiterate our rating on RTI Biologics following the beat-and-raise Q2/11 results. We believe a somewhat conservative increase in revenue and EPS guidance is warranted given the number of uncertainties in its markets. However, we note that an improving track record of management meeting and beating expectations should continue to drive an expanding multiple for the stock...We view RTI shares as still very inexpensive, trading at 19x our 2012 EPS estimate of $0.17 vs 34x for the small-cap medtech group."
For more ratings news on RTI Biologics click here and for the rating history of RTI Biologics click here.
Shares of RTI Biologics closed at $3.24 yesterday.
Canaccord analyst, William J. Plovanic, says, "We reiterate our rating on RTI Biologics following the beat-and-raise Q2/11 results. We believe a somewhat conservative increase in revenue and EPS guidance is warranted given the number of uncertainties in its markets. However, we note that an improving track record of management meeting and beating expectations should continue to drive an expanding multiple for the stock...We view RTI shares as still very inexpensive, trading at 19x our 2012 EPS estimate of $0.17 vs 34x for the small-cap medtech group."
For more ratings news on RTI Biologics click here and for the rating history of RTI Biologics click here.
Shares of RTI Biologics closed at $3.24 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Ferrovial SA (FER:SM) (FRRVF) Reiterated at Buy by UBS on Winning Bid For Tennessee Project
- Clear Street Reiterates Buy Rating on Anterix Inc. (ATEX)
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
